Cyklokapron
NDC 0013-1114, tranexamic acid, injection, solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0013-1114
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA019281
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0013-1114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID100 mg/mL
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0013-1114-15 | 00013111415 | 1 AMPULE in 1 CARTON (0013-1114-15) / 10 mL in 1 AMPULE (0013-1114-01) |
| 0013-1114-21 | 00013111421 | 10 VIAL in 1 BOX (0013-1114-21) / 10 mL in 1 VIAL (0013-1114-20) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6e89a7d9-4da4-42aa-b7f8-c602c24eefe5
Use it
Look up 0013-1114 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0013-1114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0013-1114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.